Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
41.11
+0.20 (+0.49%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Understanding GlaxoSmithKline's Unusual Options Activity
July 27, 2021
On Tuesday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved up to $39.48. Sentiment: BULLISH Option Type: SWEEP...
Via
Benzinga
Unusual Options Activity Insight: GlaxoSmithKline
July 26, 2021
On Monday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved down to $39.13. Sentiment: BEARISH Option Type: SWEEP...
Via
Benzinga
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
Analyzing GlaxoSmithKline's Unusual Options Activity
July 21, 2021
On Wednesday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved up to $39.33. Sentiment: BEARISH Option Type:...
Via
Benzinga
Don't Buy These 16 Investments In Retirement
July 21, 2021
Nearing retirement, or retired? Here are 16 investments to steer clear of.
Via
Talk Markets
Topics
Retirement
Exposures
Pension
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
July 20, 2021
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (...
Via
Benzinga
Exposures
COVID-19
Weak Week
July 16, 2021
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.
Via
Talk Markets
GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies
July 16, 2021
GlaxoSmithKline Plc (NYSE: GSK) said its anemia drug for patients with chronic kidney disease succeeded in five late-stage trials. The drug, daprodustat, an oral...
Via
Benzinga
GSK To Sell One-Third Of Its UK R&D Site For £400M
July 16, 2021
GlaxoSmithKline plc (NYSE: GSK) is planning to sell more than one-third of its 92-acre R&D site in Stevenage, the U.K. The Company is looking to sell 33...
Via
Benzinga
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
July 15, 2021
Moderna Inc (NASDAQ: MRNA) stock is on a roll, with its vaccine-induced momentum spilling over into 2021. The Massachusetts-based company, which had a modest beginning...
Via
Benzinga
Exposures
COVID-19
Dialing For Stocks
July 14, 2021
Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
5 French Stocks To Consider For Bastille Day
July 14, 2021
Bastille Day is France’s National Day, celebrating the Storming of the Bastille on July 14, 1789, a key turning point in the French Revolution. And while the French concept...
Via
Benzinga
Yellow Card
July 12, 2021
The price of oil fell about 1% today.
Via
Talk Markets
The Past Week's Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More
July 11, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Initial and secondary public offerings enticed insiders to...
Via
Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
A Look Into GlaxoSmithKline's Price Over Earnings
July 08, 2021
Looking into the current session, GlaxoSmithKline Inc. (NYSE:GSK) is trading at $39.92, after a 0.80% drop. Over the past month, the stock decreased by 0.78%, but over the...
Via
Benzinga
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
July 08, 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) have received approval from the Drug Controller General of India (DCGI) for a late-stage...
Via
Benzinga
Exposures
COVID-19
COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ
July 07, 2021
Researchers have pointed a handful of amino acids targeted by key antibodies of some people who received the AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine...
Via
Benzinga
Exposures
COVID-19
Nvidia Launches Supercomputer To Help Advance Fields Of Digital Biology, Genomics
July 07, 2021
Chip supplier Nvidia Corp (NASDAQ: NVDA) on Tuesday launched Cambridge-1, which it claims is the fastest supercomputer in the United Kingdom, dedicated to the healthcare industry...
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Why Alector Zoomed 12% Higher Today
July 06, 2021
The company has yet another fine July trading day thanks to a Citigroup analyst.
Via
The Motley Fool
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision And Conference Presentations In A Light Week
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few COVID-19 disappointments,...
Via
Talk Markets
Exposures
COVID-19
Product Safety
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
July 03, 2021
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...
Via
Benzinga
Exposures
Product Safety
People Needed
July 02, 2021
If qualified people are not looking for work, they will have to be lured to do so with higher wages.
Via
Talk Markets
Exposures
Labor
Why Alector Blasted Higher Today
July 02, 2021
It's not every day that a small biotech announces a major collaboration deal with a deep-pocketed pharmaceutical giant.
Via
The Motley Fool
Arrowhead Stock Plunges, Alector Stock Surges On Drug News
July 02, 2021
Arrowhead paused a drug study; Alector teamed up with GlaxoSmithKline to develop two drugs. Arrowhead stock sank, while Alector stock surged.
Via
Investor's Business Daily
GlaxoSmithKline's Board Backs CEO Walmsley After Elliott's Letter For Management Shakeup
July 02, 2021
GlaxoSmithKline plc (NYSE: GSK) said its board sees Chief Executive Emma Walmsley as the right person to lead its pharmaceutical business after the upcoming split...
Via
Benzinga
ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher
July 02, 2021
Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK).
Via
InvestorPlace
Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK
July 02, 2021
Alector Inc (NASDAQ: ALEC) and GlaxoSmithKline plc (NYSE: GSK) have announced a global collaboration for the development and commercialization of two...
Via
Benzinga
Is a Bigger Shake-Up at GlaxoSmithKline on the Way?
July 02, 2021
An activist investor seems to be pushing for one.
Via
The Motley Fool
New Month And Half Year
July 01, 2021
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up.
Via
Talk Markets
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.